PAT-SC1 in patients with gastric cancer

Trial Profile

PAT-SC1 in patients with gastric cancer

Phase of Trial: Phase II

Latest Information Update: 27 Sep 2011

At a glance

  • Drugs PAT SC1 (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Patrys
  • Most Recent Events

    • 27 Sep 2011 Status changed from planning to discontinued (trial is no longer being planned by Patrys).
    • 24 Dec 2010 USA FDA confirms orphan drug status and PAT-SC1 is now being converted to Patrys' recently developed large scale manufacturing technology in preparation for a second trial.
    • 27 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top